A Simple in Vivo Assay for Increased Protein Solubility

Overview

Journal Protein Sci

Specialty Biochemistry

Date 1999 Sep 24

PMID 10493593

Citations 53

Authors

K L Maxwell

A K Mittermaier

J D Forman-Kay

A R Davidson

Affiliations

Soon will be listed here.

Abstract

Low solubility is a major stumbling block in the detailed structural and functional characterization of many proteins and isolated protein domains. The production of some proteins in a soluble form may only be possible through alteration of their sequences by mutagenesis. The feasibility of this approach has been demonstrated in a number of cases where amino acid substitutions were shown to increase protein solubility without altering structure or function. However, identifying residues to mutagenize to increase solubility is difficult, especially in the absence of structural knowledge. For this reason, we have developed a method by which soluble mutants of an insoluble protein can be easily distinguished in vivo in Escherichia coli. This method is based on our observation that cells expressing fusions of an insoluble protein to chloramphenicol acetyltransferase (CAT) exhibit decreased resistance to chloramphenicol compared to fusions with soluble proteins. We found that a soluble mutant of an insoluble protein fused to CAT could be selected by plating on high levels of chloramphenicol.

Citing Articles

A random mutagenesis screen enriched for missense mutations in bacterial effector proteins.

Urbanus M, Zheng T, Khusnutdinova A, Banh D, Mount H, Gupta A G3 (Bethesda). 2024; 14(9).

PMID: 39028840 PMC: 11373652. DOI: 10.1093/g3journal/jkae158.

SAS: Split antibiotic selection for identifying chaperones that improve protein solubility.

McNutt E, Ke N, Thurman A, Eaglesham J, Berkmen M Heliyon. 2024; 10(5):e26996.

PMID: 38495176 PMC: 10943334. DOI: 10.1016/j.heliyon.2024.e26996.

Targeting Efficient Features of Urate Oxidase to Increase Its Solubility.

Reza Rahbar M, Nezafat N, Morowvat M, Savardashtaki A, Ghoshoon M, Mehrabani-Zeinabad K Appl Biochem Biotechnol. 2024; 196(9):6269-6295.

PMID: 38308671 DOI: 10.1007/s12010-023-04819-w.

Intra- a novel system to identify mutations that cause protein misfolding.

Quan N, Eguchi Y, Geiler-Samerotte K Front Genet. 2023; 14:1198203.

PMID: 37745845 PMC: 10512024. DOI: 10.3389/fgene.2023.1198203.

Biosensor Guided Polyketide Synthases Engineering for Optimization of Domain Exchange Boundaries.

Englund E, Schmidt M, Nava A, Klass S, Keiser L, Dan Q Nat Commun. 2023; 14(1):4871.

PMID: 37573440 PMC: 10423236. DOI: 10.1038/s41467-023-40464-x.

References

Vieira J, Messing J . Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene. 1985; 33(1):103-19. DOI: 10.1016/0378-1119(85)90120-9. View

Nieba L, Honegger A, Krebber C, Pluckthun A . Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Eng. 1997; 10(4):435-44. DOI: 10.1093/protein/10.4.435. View

Riordan J, Rommens J, Kerem B, Alon N, Rozmahel R, Grzelczak Z . Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989; 245(4922):1066-73. DOI: 10.1126/science.2475911. View

Schein C . Solubility as a function of protein structure and solvent components. Biotechnology (N Y). 1990; 8(4):308-17. DOI: 10.1038/nbt0490-308. View

Pan H, Clary D, Sadowski P . Identification of the DNA-binding domain of the FLP recombinase. J Biol Chem. 1991; 266(17):11347-54. View

Sudol M, Greulich H, Newman L, Sarkar A, Sukegawa J, Yamamoto T . A novel Yes-related kinase, Yrk, is expressed at elevated levels in neural and hematopoietic tissues. Oncogene. 1993; 8(4):823-31. View

Robben J, Massie G, Bosmans E, Wellens B, Volckaert G . An Escherichia coli plasmid vector system for high-level production and purification of heterologous peptides fused to active chloramphenicol acetyltransferase. Gene. 1993; 126(1):109-13. DOI: 10.1016/0378-1119(93)90597-v. View

Waugh D, Sauer R . Single amino acid substitutions uncouple the DNA binding and strand scission activities of Fok I endonuclease. Proc Natl Acad Sci U S A. 1993; 90(20):9596-600. PMC: 47616. DOI: 10.1073/pnas.90.20.9596. View

Ko Y, Thomas P, Delannoy M, Pedersen P . The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and delta F508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J Biol Chem. 1993; 268(32):24330-8. View

10.

Leistler B, Perham R . Solubilizing buried domains of proteins: a self-assembling interface domain from glutathione reductase. Biochemistry. 1994; 33(10):2773-81. DOI: 10.1021/bi00176a005. View

11.

Dale G, Broger C, Langen H, Darcy A, Stuber D . Improving protein solubility through rationally designed amino acid replacements: solubilization of the trimethoprim-resistant type S1 dihydrofolate reductase. Protein Eng. 1994; 7(7):933-9. DOI: 10.1093/protein/7.7.933. View

12.

Dyda F, Hickman A, Jenkins T, Engelman A, Craigie R, Davies D . Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 1994; 266(5193):1981-6. DOI: 10.1126/science.7801124. View

13.

Jenkins T, Hickman A, Dyda F, Ghirlando R, Davies D, Craigie R . Catalytic domain of human immunodeficiency virus type 1 integrase: identification of a soluble mutant by systematic replacement of hydrophobic residues. Proc Natl Acad Sci U S A. 1995; 92(13):6057-61. PMC: 41641. DOI: 10.1073/pnas.92.13.6057. View

14.

Murby M, Samuelsson E, Nguyen T, Mignard L, Power U, Binz H . Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus. Eur J Biochem. 1995; 230(1):38-44. DOI: 10.1111/j.1432-1033.1995.tb20531.x. View

15.

Rose R . The nucleotide sequence of pACYC184. Nucleic Acids Res. 1988; 16(1):355. PMC: 334639. DOI: 10.1093/nar/16.1.355. View